Bone Loss in Crohn's Disease

Mechanisms and Risk Factors

Uncontrolled inflammation contributes directly to bone loss through inflammatory cytokines, with approximately 35-40% of patients suffering from osteopenia and 15% from osteoporosis, according to the American Gastroenterological Association 1
Low body mass index (BMI) correlates with lower bone mineral density, indicating a potential risk factor for bone loss in Crohn's disease patients 2
Corticosteroid use is a major risk factor, with bone mineral density correlating negatively with lifetime steroid use, as recommended by the American College of Gastroenterology 1, 2
Malnutrition and weight loss contribute to bone loss, highlighting the importance of proper nutrition in managing Crohn's disease 1
Lack of physical activity further compromises bone health, emphasizing the need for regular exercise in patients with Crohn's disease 1

Patients with Crohn's disease may present with bone pain and increased fracture risk, according to the European Crohn's and Colitis Organisation 3
Secondary hyperparathyroidism may develop as a consequence of calcium malabsorption, requiring careful monitoring and management 3
All patients receiving corticosteroids should receive 800-1000 mg/day calcium and 800 IU/day vitamin D supplementation, as recommended by the American Gastroenterological Association 1, 4
Lifestyle modifications including regular physical exercise and smoking cessation are essential for maintaining bone health in Crohn's disease patients 1
Treating the underlying inflammation is important for bone health, highlighting the need for effective disease management strategies 1

Patients with high FRAX score (≥20% major fracture and ≥3% hip fracture) should have bone mineral density assessed, according to the National Osteoporosis Foundation 1
Those aged under 40 with risk factors or receiving prolonged (>3 months) or repeated courses of corticosteroids should undergo bone densitometry, as recommended by the American College of Gastroenterology 1
Monitoring vitamin D levels is important as deficiency occurs in more than half of patients with Crohn's disease, emphasizing the need for regular monitoring and supplementation 1

The European Crohn's and Colitis Organisation recommends DEXA scanning in all patients with Crohn's disease who have persistently active disease, those repeatedly exposed to corticosteroids, and patients with long disease duration 5, 6
Osteoporosis is found in 41% of patients with Crohn's disease, with a significantly higher fracture risk compared to the general population (4.8% vs 1.1%) 7, 8
The British Society of Gastroenterology guidelines indicate that osteoporosis is common in Crohn's disease and less so in ulcerative colitis 9

The American Gastroenterological Association recommends basic preventive measures including adequate calcium (500-1000 mg/day) and vitamin D (800-1000 IU/day) intake for patients with Crohn's disease 5, 8
Pancreatic enzyme supplementation is recommended if indicated for malabsorption, and regular weight-bearing exercise and avoidance of smoking and alcohol are advised 5, 8
In post-menopausal women with osteoporosis, regular use of bisphosphonates, calcitonin and its derivatives, and raloxifene reduce or prevent further bone loss 5, 6
In males with osteoporosis, bisphosphonates are probably of value 5, 6

The presence of osteoporosis is one risk factor for fractures; vertebral fractures have been documented in patients with both reduced and normal bone density 5, 6
The strongest predictor of future fracture is a prior vertebral fracture 5, 6
Patients with Crohn's disease receiving pancreatic enzyme replacement therapy for fat malabsorption had a lower risk of fractures than other Crohn's patients 8